Proteomics analysis of protein biomarkers in Astragalus membranaceus- and Astragaloside IV-treated brain tissues in ischemia-reperfusion injured rats

10.1016/j.jtcme.2021.04.002

Wan-Yu Lo；Chung-Hsiang Liu；Chao-Hsiang Chen；Ching-Liang Hsieh

Protein biomarker ； Astragalus membranaceus ； Astragaloside IV ； Brain tissue ； Ischemia-reperfusion injury

Journal of Traditional and Complementary Medicine

11卷4期（2021 / 07 / 01）

369 - 374

英文

Background and aim: Astragalus membranaceus (AM) is a major Chinese herb used in the treatment of stroke. Astragaloside IV (AS)is a component of AM. This study investigated the effects of AM on the protein expression through proteomics analysis in ischemia-reperfusion injured Sprague Dawley rats. Experimental procedure: An animal model of ischemia-reperfusion injury by occlusion of the right middle cerebral artery for 90 min followed by reperfusion for 24 h. The rats were intraperitoneally injected with AM or AS three times at 30 min, 1 day, and 2 days prior to the occlusion of the cerebral blood flow. Results: Aldolase C was overexpressed in the cortex, and Dihydrolipoamide dehydrogenase and Triosephosphate isomerase were overexpressed in the hippocampus. Conclusion: Pretreatment with AM or AS can induce the overexpression of Aldolase C in the cerebral cortex and that of Dihydrolipoamide dehydrogenase and Triose-phosphate isomerase in the hippocampus, suggesting that both AM and AS may act as neuroprotectors through regulating the expression of Aldolase C, Dihydrolipoamide dehydrogenase and Triose-phosphate isomerase. However, the underlying neuroprotective mechanisms need more studies.

1. Arakaki, TL,Pezza, JA,Cronin, MA(2004).Structure of human brain fructose 1,6-(bis)phosphate aldolase: linking isozyme structure with function.Protein Sci,13(12),3077-3084.
2. Auriel, E,Bornstein, NM(2010).Neuroprotection in acute ischemic stroke–current status.J Cell Mol Med.,14(9),2200-2202.
3. Buono, P,Barbieri, O,Alfieri, A(2004).Diverse human aldolase C gene promoter regions are required to direct specific LacZ expression in the hippocampus and Purkinje cells of transgenic mice.FEBS Lett,578(3),337-344.
4. Butterfield, DA,Perluigi, M,Sultana, R(2006).Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.Eur J Pharmacol,545(1),39-50.
5. Caspi, M,Perry, G,Skalka, N(2014).Aldolase positively regulates of the canonical Wnt signaling pathway.Mol Canc,13,164.
6. Chen, CC,Lee, HC,Chang, JH(2012).Chinese herb Astragalus membranaceus enhances recovery of hemorrhagic stroke: double-blind, placebo-controlled, randomized study.Evid base Compl Alternative Med,2012,708452.eCAM.
7. Chen、 J,Chen, T,Huang, Qi, Radix(2004).Chinese Medical Herbology and Pharmacology.
8. Cheng, CY,Su, SY,Tang, NY,Ho, TY,Chiang, SY,Hsieh, CL(2008).Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats.Brain Res,1209,136-150.
9. Di Domenico, F,Casalena, G,Jia, J(2012).Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion.J Neurochem,121(4),680-692.
10. Fujita, H,Aoki, H,Ajioka, I(2014).Detailed expression pattern of aldolase C (Aldoc) in the cerebellum, retina and other areas of the CNS studied in Aldoc-Venus knock-in mice.PloS One,9(1)
11. Gui, D,Guo, Y,Wang, F(2012).Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.PloS One,7(6)
12. Igamberdiev, AU,Bykova, NV,Ens, W,Hill, RD(2004).Dihydrolipoamide dehydrogenase from porcine heart catalyzes NADH-dependent scavenging of nitric oxide.FEBS Lett,568(1-3),146-150.
13. Kischel, P,Waltregny, D,Castronovo, V(2007).Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.Expet Rev Proteonomics,4(6),727-739.
14. Krapfenbauer, K,Engidawork, E,Cairns, N,Fountoulakis, M,Lubec, G(2003).Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders.Brain Res.,967(1-2),152-160.
15. Langellotti, S,Romano, M,Guarnaccia, C(2014).A novel anti-aldolase C antibody specifically interacts with residues 85-102 of the protein.mAbs,6(3),708-717.
16. Liu, G,Song, J,Guo, Y,Wang, T,Zhou, Z(2013).Astragalus injection protects cerebral ischemic injury by inhibiting neuronal apoptosis and the expression of JNK3 after cerebral ischemia reperfusion in rats.Behav Brain Funct,9,36.
17. Liu, XY,Yang, JL,Chen, LJ(2008).Comparative proteomics and correlated signaling network of rat hippocampus in the pilocarpine model of temporal lobe epilepsy.Proteomics,8(3),582-603.
18. Lo, WY,Tsai, FJ,Liu, CH(2010).Uncaria rhynchophylla upregulates the expression of MIF and cyclophilin A in kainic acid-induced epilepsy rats: a proteomic analysis.Am J Chin Med.,38(4),745-759.
19. Lo, WY,Tsai, MH,Tsai, Y(2007).Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis.Clin Chim Acta,376(1-2),101-107.
20. Luo, Y,Qin, Z,Hong, Z(2004).Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.Neurosci Lett,363(3),218-223.
21. Mhawech-Fauceglia, P,Wang, D,Kesterson, J(2011).Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology.Histopathology,59(5),1015-1018.
22. Ritterson Lew, C,Tolan, DR(2012).Targeting of several glycolytic enzymes using RNA interference reveals aldolase affects cancer cell proliferation through a non-glycolytic mechanism.J Biol Chem,287(51),42554-42563.
23. Roger, VL,Go, AS,Lloyd-Jones, DM(2011).Heart disease and stroke statistics- 2011 update: a report from the American Heart Association.Circulation,123(4),e18-e209.
24. Slemmer, JE,Haasdijk, ED,Engel, DC,Plesnila, N,Weber, JT(2007).Aldolase C-positive cerebellar Purkinje cells are resistant to delayed death after cerebral trauma and AMPA-mediated excitotoxicity.Eur J Neurosci.,26(3),649-656.
25. Warburg O, Wind F, Negelein E. The metabolism OF tumors IN the body. J Gen Physiol. 1927;8(6):519-530.
26. Wierenga, RK,Kapetaniou, EG,Venkatesan, R(2010).Triosephosphate isomerase: a highly evolved biocatalyst.Cell Mol Life Sci.,67(23),3961-3982.
27. Wilkins, MR(2002).What do we want from proteomics in the detection and avoidance of adverse drug reactions.Toxicol Lett,127(1-3),245-249.
28. Wilkins, MR,Sanchez, JC,Gooley, AA(1996).Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.Biotechnol Genet Eng Rev,13,19-50.
29. Yin, YY,Li, WP,Gong, HL,Zhu, FF,Li, WZ,Wu, GC(2010).Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats.Am J Chin Med,38(3),517-527.